News

Treasury yields tick higher as traders look ahead to more economic data releases

Treasury yields moved higher as investors look ahead to more key economic data releases this week.

Pharma major plummets over 10% after third trial disappointment in a week

Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial disappointed investors.

Global shipping authorities warn of maritime trade breakdown amid geopolitical turmoil

Eighteen maritime bodies warned Tuesday that geopolitical tensions and a growing shadow fleet threaten to undermine international shipping and weaken trade.

Canada's retaliatory tariffs worth $27.6 billion take effect as trade rift with U.S. deepens

Duties on U.S. steel and aluminum products have doubled to 50% as a war of words between Washington and Ottawa continues.

Scammers demand ransoms from Instagram users over fake copyright claims

Users say they are losing money or risk having their accounts suspended because Meta struggles to identify scammers.

CNBC Daily Open: Brent crude barrels back towards $100

Oil prices march higher as ship and refinery attacks intensify in the Middle East.

It's been a rough month of natural disasters. Here's a review of some of the worst

Natural disasters have intensified in the past month as the super El Nino phenomenon takes effect.

Mistral bags $24 billion valuation as Samsung leads funding for Europe's AI champion

Mistral is betting on open-weight AI models to help it compete with players like OpenAI and Anthropic.

Cholesterol drug setback casts doubt over multibillion-dollar race 

AMGN, AMGNN, AMGNCL, AMGD, AMGN0, AMGN1, AMGNCL0, AMGNCL1

Novartis’ failure raises the stakes for Amgen and Eli Lilly in the race to turn lower Lp(a) levels into fewer heart attacks and strokes.

'JLR job cuts a cause for uncertainty and worry'

PST0, VATE

Experts say they worry it could limit the company's ability to innovate in the future.